PAR 1.79% 27.5¢ paradigm biopharmaceuticals limited..

Why Zilosul could be a golden goose!!, page-35

  1. 4,210 Posts.
    lightbulb Created with Sketch. 6686
    We can't...we dont have the distribution network...partnering for purely overnight distribution mass network is the way to go.


    It will cost us circa 70% lost revenue...30% is enough.


    Case example

    Humira (RA)

    Year 1 200 mil
    2 280 mil
    3 852 mil
    4 1400 mil

    ..
    ..
    19 19,832 mil


    I know what you are already jumping too..Mozz...30% (royalty) of those figs aint too much when distributed across your SOI.


    Mate RA...is one tenth size of OA


    But even that is nothing...I'm talking PAIN and a fair few inflammatory conditions in general...
    Much bigger than OA.


    Highly spec statements here..could be years off...
    Ok months...haha...go years, better to be conservative and not be disappointed!



    ps: Who knows, maybe we go Aussie and NZ on our own...leave rest for Global distrib. partnership...once we have serious ARGs we wont care, the SP will wake up.



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.